Psychedelic Science, Ethics, and Business

The Psychedelic Science, Ethics & Business event at ICPR 2022 features world-leading experts in science, business, investing and ethics, including David Nichols (Heffter), Amy Emerson (MAPS PBC), David Nutt (Imperial College) and Shayla Love (VICE).

Science, Ethics & Business in Psychedelics brings together 400 attendees and world-class speakers who are shaping the rapidly expanding psychedelic ecosystem. Join us on Wednesday the 21st of September, for a front-row seat to leading thinkers in psychedelic business, research, and academia.  

The full day is dedicated to an in-depth and critical discussion about the intersection of psychedelic research, treatments, and investment. We'll discuss how the growing economy around psychedelics impacts science and therapy. Featuring leading experts from psychedelic businesses, academia, non-profit organisations, and investment companies.

We'll ask what is needed to bridge the gap between lab and patients? We'll inquire how investments and the proliferation of startups can be made compatible with core values and public benefit, such as optimal patient care, accessible, and equitable treatments. We'll consider and compare different potential business models around psychedelics, and what that means for access and quality. And much more!

If you're an entrepreneur, investor, executive, researcher, clinician, or someone who cares about these developments, you will walk away from this conference with unique insights into how psychedelic science is translated into practice.